Dr. Ronald Tuma is a full professor Department of Neurosurgery and researcher at Temple University School of Medicine in Philadelphia. His laboratory is currently focused on the therapeutic potential of cannabinoid-based compounds in the treatment of CNS disorders associated with inflammation. Current animal models being studied include stroke, multiple sclerosis, spinal cord injury, neuropathic pain, substance use and dependence, and traumatic brain injury. The pharmacotherapies being explored are the non-psychoactive plant-based cannabinoid Cannabidiol and synthetic compounds which act on non-psychoactive cannabinoid receptors in the body. He is a graduate of Muhlenberg College in Pennsylvania and received his Ph.D. in Physiology from Temple University. He currently holds appointments in the Center for Substance Abuse Research and the Department of Neurosurgery at the Temple University School of Medicine.